Predictive Oncology Inc.
1.25
-0.03 (-2.34%)
At close: Jan 14, 2025, 3:59 PM
1.20
-4.00%
Pre-market Jan 15, 2025, 07:00 AM EST
undefined%
Bid 1.18
Market Cap 8.33M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.96
PE Ratio (ttm) -0.42
Forward PE n/a
Analyst Buy
Ask 1.27
Volume 217,809
Avg. Volume (20D) 1,146,422
Open 1.28
Previous Close 1.28
Day's Range 1.19 - 1.31
52-Week Range 0.55 - 3.76
Beta undefined

About POAI

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery usi...

Sector Healthcare
IPO Date May 3, 2010
Employees 34
Stock Exchange NASDAQ
Ticker Symbol POAI

Analyst Forecast

According to 2 analyst ratings, the average rating for POAI stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 140.00% from the latest price.

Buy 50.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts
1 week ago · Source
+57.5%
Predictive Oncology shares are trading higher afte... Unlock content with Pro Subscription
1 week ago · Source
+12.2%
Predictive Oncology shares are trading higher after announcing the company is evaluating strategic alternatives including a potential sale.